Matthew Piers Akerman

Matthew Piers Akerman

Auto-generated profile, based on publicly available information

Matthew Piers Akerman

School of Chemistry and Physics, University of KwaZulu-Natal, Pietermaritzburg, SOUTH AFRICA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2014 in Journal of the American Chemical Society
Verified
Journal Article
Open access
KAKate J. Akerman
Kate J. Akerman
AFAlexander Fagenson
Alexander Fagenson
VCVidusha Cyril
Vidusha Cyril
MTMichael Taylor
Michael Taylor
MMMark T. Muller
Mark T. Muller
OMOrde Q. Munro
Orde Q. Munro
Topoisomerase IB (Top1) is a key eukaryotic nuclear enzyme that regulates the topology of DNA during replication and gene transcription. Anticancer drugs that block Top1 are either well-characterized interfacial poisons or lesser-known catalytic inhibitor compounds. Here we describe a new class of cytotoxic redox-stable cationic Au3+ macrocycles which, through hierarchical cluster analysis of cytotoxicity data for the lead compound, 3, were identified as either poisons or inhibitors of Top1. Two pivotal enzyme inhibition assays prove that the compounds are true catalytic inhibitors of Top1. Inhibition of human topoisomerase IIα (Top2α) by 3 was 2 orders of magnitude weaker than its inhibition of Top1, confirming that 3 is a type I-specific catalytic inhibitor. Importantly, Au3+ is essential for both DNA intercalation and enzyme inhibition. Macromolecular simulations show that 3 intercalates directly at the 5′-TA-3′ dinucleotide sequence targeted by Top1 via crucial electrostatic interactions, which include π–π stacking and an Au···O contact involving a thymine carbonyl group, resolving the ambiguity of conventional (drug binds protein) vs unconventional (drug binds substrate) catalytic inhibition of the enzyme. Surface plasmon resonance studies confirm the molecular mechanism of action elucidated by the simulations.


15 April 2019 in ChemElectroChem
Verified
Journal Article
Closed access
PDF file
CGCharles Gervas
Charles Gervas
MKMalik Dilshad Khan
Malik Dilshad Khan
SMSixberth Mlowe
Sixberth Mlowe
CZChunyang Zhang
Chunyang Zhang
CZChen Zhao
Chen Zhao
NRNeerish Revaprasadu
Neerish Revaprasadu

1 May 2015 in Journal of Organometallic Chemistry
Verified
Journal Article
Closed access
GNGeorge S. Nyamato
George S. Nyamato
MAMohd Gulfam Alam
Mohd Gulfam Alam
SOStephen O. Ojwach
Stephen O. Ojwach
MAMatthew P. Akerman
Matthew P. Akerman

1 January 2017 in Polyhedron
Verified
Journal Article
Closed access
CGCharles Gervas
Charles Gervas
SMSixberth Mlowe
Sixberth Mlowe
MAMatthew P. Akerman
Matthew P. Akerman
IEItegbeyogene Ezekiel
Itegbeyogene Ezekiel
TMThomas Moyo
Thomas Moyo
NRNeerish Revaprasadu
Neerish Revaprasadu

14 January 2016 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
GNGeorge S. Nyamato
George S. Nyamato
Stephen OjwachStephen Ojwach
Stephen Ojwach
MAMatthew P. Akerman
Matthew P. Akerman
Activation of (amino)pyridine nickel( ii ) complexes 1–4 with either EtAlCl 2 or methylaluminoxane (MAO), produced active ethylene oligomerization catalysts to afford mostly butenes and hexenes and octenes as minor products.